A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Trastuzumab|DRUG: Paclitaxel|DRUG: Lapatinib
Sponsor: Cancer Trials Ireland